Eurofins Scientific SE Q1 and Q2 2025 Earnings Update

Eurofins Scientific SE, a life sciences tools and services company, has released its Q1 and Q2 2025 earnings call transcripts. Key highlights from the reports include:

• The company’s stock price has experienced fluctuations in the market.
• Eurofins has announced its sixth buy-back program, aiming to purchase up to 4.5% of its share capital.

Market Performance

The European stock market has experienced a recovery from early weakness. Eurofins’ peers have reported mixed quarterly results.

Global Operations

Eurofins’ operations and services continue to expand globally, with a presence in over 800 laboratories across 47 countries.

Note: The information provided is based on publicly available data and may not reflect the company’s current financial situation or future performance.